⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 3, 2025Open Access

Table 1 from Novel Afro-Caribbean Prostate Cancer Model Reveals Ancestry-Specific Drug Vulnerabilities with Therapeutic Implications for Black Patients

Simone Badal Bor-Jang Hwang Ashlianne Nelson Kristoff Frank Tanisha Maitre Magdalene Nwokocha Rory Thompson Belinda Morrison Rajini Haraksingh Valerie Odero‐Marah Camille Ragin

View Full Paper

Ask AI

Bookmark

Share

Key Points

Ancestry-specific drug vulnerabilities were identified, indicating tailored treatment approaches may enhance efficacy.
The analysis included a review of drug concentration ranges based on previously published studies in prostate cancer therapies.
The findings underscore the need for consideration of ancestry in therapeutic approaches for prostate cancer treatment.
This novel model provides insights that could improve clinical outcomes for Black patients facing prostate cancer.

Implication

Observational analysis reveals ancestry-specific drug vulnerabilities in prostate cancer, highlighting implications for Black patients.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Badal et al. (2025) studied this question.

synapsesocial.com/papers/68e03501f0e39f13e7fa399e https://doi.org/10.1158/2767-9764.30268426

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Data from Novel Afro-Caribbean Prostate Cancer Model Reveals Ancestry-Specific Drug Vulnerabilities with Therapeutic Implications for Black Patients2025
2Novel Afro-Caribbean Prostate Cancer Model Reveals ancestry-specific Drug Vulnerabilities with Therapeutic Implications for Black Patients2025 · 10 citations
3Abstract C054: Current anticancer drugs differentially impact Black and White prostate cancer cell lines2024
4Underrepresentation of Black Patients in Preclinical Prostate Cancer Models2025
5Abstract 23: Pharmacogenomics of Breast, Cervical and Prostate Cancers: Cytochrome P450 Variants and Implications for Chemotherapy in African Populations2025

More related papers

Table S1 from Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures2024
Sub-Saharan African Prostate Cancer Patient-Derived Cell Lines and High-Throughput Drug Screening: Addressing Ancestry Underrepresentation in Oncobiology Research2026
Abstract 3381: Diversifying the breast cancer cell line repository with ACRJ-BC24, ACRJ-BC24α, and ACRJ-BC24β: Novel TNBC cell lines derived from an Afro-Caribbean patient2024